Compare · APT vs ZBH
APT vs ZBH
Side-by-side comparison of Alpha Pro Tech Ltd. (APT) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APT and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $18.00B, about 308.4x APT ($58.4M).
- APT has been more active in the news (14 items in the past 4 weeks vs 13 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 0 for APT).
- Company
- Alpha Pro Tech Ltd.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $58.4M
- $18.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- AMEX
- NYSE
- IPO
- 2000
- News (4w)
- 14
- 13
- Recent ratings
- 0
- 25
Alpha Pro Tech Ltd.
Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap, synthetic roof underlayment, and other woven materials. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites; and pharmaceutical markets. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest APT
- Director Ritota John was granted 5,860 shares, increasing direct ownership by 14% to 47,215 units (SEC Form 4)
- Director Shaw Benjamin A was granted 5,860 shares, increasing direct ownership by 57% to 16,215 units (SEC Form 4)
- Director Buchan James was granted 5,860 shares, increasing direct ownership by 104% to 11,475 units (SEC Form 4)
- Director Garcia David R was granted 5,860 shares, increasing direct ownership by 30% to 25,628 units (SEC Form 4)
- Director Montgomery Charles D covered exercise/tax liability with 13,057 shares, sold $110,593 worth of shares (21,943 units at $5.04) and was granted 33,000 shares, decreasing direct ownership by 3% to 58,281 units (SEC Form 4)
- Amendment: Director Montgomery Charles D sold $152,319 worth of shares (23,886 units at $6.38), decreasing direct ownership by 28% to 60,281 units (SEC Form 4)
- CEO AND PRESIDENT Hoffman Lloyd covered exercise/tax liability with 26,765 shares and was granted 45,000 shares, increasing direct ownership by 7% to 273,750 units (SEC Form 4)
- Director Millar Donna covered exercise/tax liability with 8,029 shares, sold $35,134 worth of shares (6,971 units at $5.04) and was granted 15,000 shares (SEC Form 4)
- CFO Mcdonald Colleen J covered exercise/tax liability with 16,059 shares and was granted 27,000 shares, increasing direct ownership by 20% to 66,774 units (SEC Form 4)
- Amendment: CEO AND PRESIDENT Hoffman Lloyd was granted 50,000 shares, increasing direct ownership by 69% to 122,505 units (SEC Form 4)
Latest ZBH
- ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
- Barclays initiated coverage on Zimmer Biomet with a new price target
- Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
- SEC Form 4 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Shapiro Louis